Amazing value implied for NEU. He puts the value of Trof to Acadia right now at $US4.66 per share based on the US market alone rising to $US7.77 upon FDA approval.
Consider
- double digit royalties
- sale of ROW right
- double digit ROW royalties
- share of the sale of the Voucher
- milestone payments
- the almost forgotten Fragile x
- entire potential value of the other molecule.
No wonder Karst Peak and Midford are backing up the truck.
Acadia - Catalysts Stacking, page-4
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.56 |
Change
-0.360(2.59%) |
Mkt cap ! $1.733B | |||
| Open | High | Low | Value | Volume |
| $13.94 | $13.96 | $13.50 | $6.421M | 470.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1643 | $13.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.61 | 3100 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |